Literature DB >> 19584200

Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.

Emil Egecioglu1, Karolina Ploj, Xiufeng Xu, Mikael Bjursell, Nicolas Salomé, Niklas Andersson, Claes Ohlsson, Magdalena Taube, Caroline Hansson, Mohammad Bohlooly-Y, David G A Morgan, Suzanne L Dickson.   

Abstract

To investigate the role of the central neuromedin U (NMU) signaling system in body weight and energy balance regulation, we examined the effects of long-term intracerebroventricular (icv) infusion of NMU in C57Bl/6 mice and in mice lacking the gene encoding NMU receptor 2. In diet-induced obese male and female C57BL/6 mice, icv infusion of NMU (8 microg x day(-1) x mouse(-1)) for 7 days decreased body weight and total energy intake compared with vehicle treatment. However, these parameters were unaffected by NMU treatment in lean male and female C57BL/6 mice fed a standard diet. In addition, female (but not male) NMUR2-null mice had increased body weight and body fat mass when fed a high-fat diet but lacked a clear body weight phenotype when fed a standard diet compared with wild-type littermates. Furthermore, female (but not male) NMUR2-null mice fed a high-fat diet were protected from central NMU-induced body weight loss compared with littermate wild-type mice. Thus, we provide the first evidence that long-term central NMU treatment reduces body weight, food intake, and adiposity and that central NMUR2 signaling is required for these effects in female but not male mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584200     DOI: 10.1152/ajpendo.91022.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  10 in total

Review 1.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

2.  Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight.

Authors:  C R Benzon; S B Johnson; D L McCue; D Li; T A Green; J D Hommel
Journal:  Neuroscience       Date:  2013-11-20       Impact factor: 3.590

Review 3.  Obesity pharmacotherapy: current perspectives and future directions.

Authors:  Monika Misra
Journal:  Curr Cardiol Rev       Date:  2013-02-01

4.  Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models.

Authors:  Catherine M Sampson; James M Kasper; Daniel E Felsing; Sweta R Raval; Na Ye; Pingyuan Wang; Igor Patrikeev; Erik Rytting; Jia Zhou; John A Allen; Jonathan D Hommel
Journal:  Pharmacol Res Perspect       Date:  2018-08-23

5.  Binge-Type Eating in Rats is Facilitated by Neuromedin U Receptor 2 in the Nucleus Accumbens and Ventral Tegmental Area.

Authors:  Ashley E Smith; James M Kasper; Noelle C Anastasio; Jonathan D Hommel
Journal:  Nutrients       Date:  2019-02-02       Impact factor: 5.717

6.  Brain region-specific neuromedin U signalling regulates alcohol-related behaviours and food intake in rodents.

Authors:  Daniel Vallöf; Aimilia Lydia Kalafateli; Elisabet Jerlhag
Journal:  Addict Biol       Date:  2019-05-08       Impact factor: 4.280

Review 7.  Neuromedin U, a Key Molecule in Metabolic Disorders.

Authors:  Hitoshi Teranishi; Reiko Hanada
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

8.  A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents.

Authors:  Louise S Dalbøge; Philip J Pedersen; Gitte Hansen; Katrine Fabricius; Henrik B Hansen; Jacob Jelsing; Niels Vrang
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

9.  The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice.

Authors:  Daniel Vallöf; Jesper Vestlund; Jörgen A Engel; Elisabet Jerlhag
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

10.  Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents.

Authors:  Daniel Vallöf; Lisa Ulenius; Emil Egecioglu; Jörgen A Engel; Elisabet Jerlhag
Journal:  Addict Biol       Date:  2016-01-14       Impact factor: 4.280

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.